Phase I Study of Window of Opportunity for Neoadjuvant Stroma Modification in Pancreatic Cancer
Summary
The purpose of this study to test the safety and feasibility of Paricalcitol, hydroxychloroquine, and losartan in patients with resectable pancreatic cancer.
General Information
NCT#: NCT05365893
Study ID: GI-174
Trial Phase: Phase I
Trial Sponsor: Fox Chase Cancer Center
Therapies Used in This Trial: Hydroxychloroquine, Losartan, Paricalcitol